Express News | Vanda Pharmaceuticals Shares up 2% Premarket After Its Motion Sickness Treatment Succeeds in a Late-Stage Confirmatory Study
Express News | Vanda Pharmaceuticals: 2Nd Phase III Study Showed Tradipitant Is Effective in Prevention of Vomiting Associated With Motion Sickness
Express News | Vanda Pharmaceuticals Inc - New Drug Application Expected to Be Submitted in Q4 2024
Express News | Vanda Pharmaceuticals Reports Positive Results From a Second Phase III Study of Tradipitant in Motion Sickness
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
Earnings Call Summary | Vanda Pharmaceuticals(VNDA.US) Q1 2024 Earnings Conference
The following is a summary of the Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript:Financial Performance:Vanda Pharmaceuticals posted total revenues of $47.5 million for Q1 2024, re
Vanda Pharmaceuticals | 10-Q: Quarterly report
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Other Big Stocks Moving Lower
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.Shares of Exact Sciences Corporation (NASDAQ:EXAS) fell sharply in today's pre-market trading aft
Express News | Vanda Pharmaceuticals Shares Down 7.1% Premarket After Q1 Loss Vs Year-Ago Profit
Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript
Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript
Vanda Pharma Q1 2024 GAAP EPS $(0.07) Misses $0.05 Estimate, Sales $47.462M Miss $48.500M Estimate
Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.05 by 240 percent. The company reported quarterly sales of $47.462 million
Express News | Vanda Pharmaceuticals Inc: Revenues for Q1 2024 Were $47.5 Mln
Express News | Vanda Pharmaceuticals Inc - Unable to Provide 2024 Financial Guidance at This Time
Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M
04:01 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M
Express News | Vanda Pharmaceuticals Q1 EPS USD -0.07
Express News | Vanda Pharmaceuticals Q1 Operating Income USD -9.235 Million
Express News | Vanda Pharmaceuticals Q1 Net Income USD -4.146 Million
Express News | Vanda Pharmaceuticals Q1 Operating Expenses USD 56.697 Million
Express News | Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results